NLRP3炎症酶对肺癌免疫微环境激活的影响及其机制
Alternative therapies in health and medicine
|April 30, 2024
概括
NLRP3炎症酶激活促进肺癌细胞的增殖和迁移. 用IL-1RA和IL-18BP阻断这种途径可以逆转这些影响,从而影响患者的预后.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- NLRP3炎症酶在瘤发育中起着复杂的作用,其在肺癌中的具体功能尚不清楚.
- 了解NLRP3炎症酶对肺癌的影响对于开发向疗法至关重要.
研究的目的:
- 研究NLRP3炎症酶激活对肺癌细胞增殖和迁移的影响.
- 分析NLRP3表达和肺腺癌患者预后之间的关系.
主要方法:
- 使用公共数据库 (GEPIA,TCGA,HPA) 进行表达式分析.
- 进行了CCK-8和scratch测试,以评估细胞增殖和迁移.
- 研究了NLRP3炎症酶抑制剂 (IL-1RA,IL-18BP) 的作用,并进行了生存分析.
主要成果:
- 肺癌组织中NLRP3的表达低于正常组织,但在瘤相关的巨细胞中更高.
- NLRP3炎症酶激活增强了A549细胞的增殖和迁移.
- 抑制NLRP3炎症酶可以逆转这些前瘤性影响.
- 高NLRP3表达与较差的患者预后相关 (HR=1.44).
结论:
- NLRP3炎症酶激活促进肺癌细胞的增殖和迁移,可能通过IL-1β和IL-18分泌.
- 阻断IL-1β和IL-18可以抵消这些影响.
- NLRP3炎症酶活性是肺腺癌的潜在预后标志物.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K


